Skip to main content

Table 3 CES-D: Responder rates at follow-ups

From: Anthroposophic therapy for chronic depression: a four-year prospective cohort study

Follow-up month

CES-D improved from baseline

 

CES-D improved from baseline by ≥ 50%

 

CES-D ≤ 23 (not depressed)

 
 

Proportion of evaluable patients

Proportion of all patients

Proportion of evaluable patients

Proportion of all patients

Proportion of evaluable patients

Proportion of all patients

 

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

3

59/67 (88%)

59/79 (75%)

21/67 (31%)

21/79 (27%)

39/67 (58%)

39/79 (49%)

6

60/69 (87%)

60/79 (79%)

27/69 (39%)

27/79 (34%)

47/69 (68%)

47/79 (59%)

12

54/62 (87%)

54/79 (68%)

32/62 (52%)

32/79 (41%)

41/62 (66%)

41/79 (52%)

18

50/59 (85%)

50/79 (63%)

33/59 (56%)

33/79 (42%)

41/59 (69%)

41/79 (52%)

24

54/60 (90%)

54/79 (68%)

31/60 (52%)

31/79 (41%)

40/60 (67%)

40/79 (51%)

48

43/48 (90%)

43/79 (54%)

28/48 (56%)

28/79 (35%)

37/48 (77%)

37/79 (47%)

  1. Patients enrolled after 1.1.99. CES-D: Center for Epidemiological Studies Depression Scale, German version